创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the unique advantages of a humanized model of the immune system?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-22 10:34
  • Views:

(Summary description)With the continuous progress of science and technology, mankind's understanding of living organisms has gradually deepened. In the medical field, in order to better simulate the human environment for disease research and drug screening, scientists have developed humanized models. The humanized model of immune system of InnoModels Biotechnology, with its unique advantages, has brought a new dawn for medical research

InnoModels Biotechnology: What are the unique advantages of a humanized model of the immune system?

(Summary description)With the continuous progress of science and technology, mankind's understanding of living organisms has gradually deepened. In the medical field, in order to better simulate the human environment for disease research and drug screening, scientists have developed humanized models. The humanized model of immune system of InnoModels Biotechnology, with its unique advantages, has brought a new dawn for medical research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-22 10:34
  • Views:
Information

With the continuous progress of science and technology, mankind's understanding of living organisms has gradually deepened. In the medical field, in order to better simulate the human environment for disease research and drug screening, scientists have developed humanized models. The humanized model of immune system of InnoModels Biotechnology, with its unique advantages, has brought a new dawn for medical research.
I. High Stability: Stable Reconstruction of Immune System
Traditional immune system models often face stability problems, and the reproducibility of experimental results is not strong, resulting in scientific research being hindered. However, the humanized model of the immune system of InnoModels Biotechnology has successfully solved this problem by virtue of its high stability. After improvement, the success rate of experimental modeling has increased from the original 50% to an amazing 87%. This means that researchers can have more confidence in the reliability of the experimental results and conduct in-depth investigations on the basis of using the model of InnoModels.
In addition to the increase in modeling success rate, the stability of the model from InnoModels Biotechnology is also reflected in the significant reduction of the within-group coefficient of variation. The intra-group coefficient of variation is an important indicator of the consistency of experimental results, and the lower its value, the less fluctuation of experimental results and the more stable they are. After optimization, the within-group coefficient of variation of the model has been drastically reduced from the original 120% to 20%, providing more reliable experimental data for researchers.

 


Multi-cell reconstruction: industry-leading all-round simulation
The immune system is a complex network involving the interaction of multiple immune cells. In order to more realistically simulate the human immune system, InnoModels' model realizes multi-cell reconstruction. This includes a variety of immune cells such as T-cells, B-cells, NK-cells, macrophages, DC-cells and so on. Each cell plays its unique role in the model, and together they form a complete immune system network.
Through multicellular reconstruction, the model from InnoModels Biotechnology is able to more comprehensively simulate the responses and changes of the human immune system. Researchers can use these models to study the interactions between different cells, investigate the mechanisms of disease onset and progression, and evaluate the effects of drugs on the immune system. This all-encompassing simulation capability makes InnoModels' models a leader in the industry.
III. Close to Human Concentration: Providing a Realistic Environment for Drug Testing
Drug testing is an important part of medical research, and its results are directly related to the safety and effectiveness of drugs. In order to more accurately assess the effects of drugs, a testing platform close to the real environment of the human body is needed. The humanized model of the immune system of InnoModels Biotechnology meets this need.
The reconstructed number of immune cells in the model can reach or approach the concentration of human immune cells, providing a more realistic environment for drug testing. This means that researchers can simulate the metabolism and action process of drugs in the human body in the model, and predict the effects of drugs on the immune system, so as to screen for safer and more effective drugs.
In summary, the humanized model of the immune system by InnoModels Biotechnology has brought new breakthroughs in medical research with its advantages of high stability, multi-cell reconstruction and close concentration to the human body. With the continuous improvement and application of this model, it is believed that future medical research will be more in-depth, precise and efficient.

Keyword:

In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司